The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Established indications

Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial

EuroIntervention 2011;7:K61-K65.

coronary artery disease bifurcation drug-eluting balloon angiographic follow-up Abstract

Aims: Percutaneous coronary interventions for bifurcation lesions are often complex and associated with an unsatisfactory result. The aim of this first-in-man, observational study was to investigate the efficacy and safety of a paclitaxel-eluting balloon in these lesions.

Methods and results: Twenty-eight patients presenting significant coronary bifurcational lesions of the left coronary artery were studied. The main branch (MB) and the side branch (SB) were dilated with a drug-eluting balloon (DEB; SeQuent® Please balloon catheter , 3µg paclitaxel/mm2 balloon surface). An open-cell bare-metal stent (BMS; Coroflex®) was then deployed in ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study